The study is a prospective, multicenter study following patients for two years. The study was conducted through the International Spine Study Group and included 286 operative and 403 nonoperative patients who underwent treatment for spinal deformity.
After comparing baseline measures and outcomes between the two groups of patients with unmatched and propesity matched analysis, the study authors found:
- Significant improvement for the operative patients across multiple measures of health-related quality of life that assessed general health, pain and disability.
- The nonoperative patients did not demonstrate significant change in any of the standardized measures of health-related quality of life.
- Results suggested nonoperative treatment, at best, maintained presenting levels of pain and disability after two years.
“This is a timely and useful study because our aging population will be facing more symptomatic spinal degeneration and deformity than ever,” said NASS Annual Meeting Program Chair Charles Reitman, MD, professor and vice chair of orthopedic surgery at Baylor College of Medicine. “However, as technology and surgical expertise continue to grow, it is critical that additional research be done to insure understanding of appropriate surgical indiciations so that utilization of surgery as well as outcomes for these patients may be optimized.”
More articles on spine surgery:
Where spine device companies stand in 3Q—76 things to know
SI joint fusion could explode by 2020—5 things to know
8 key trends in the U.S. minimally invasive spine technology market
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.